Gallacher Capital Management LLC

Position in NVO — Novo Nordisk A S

CIK 1960749 LONE TREE, CO

Position in NVO

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$549,440

+$215,015 QoQ

Shares Held

11,461

+25.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

#680

of 1,348 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gallacher Capital Management LLC holds $3,790,927 across 9 Drug Manufacturers - General names. NVO ranks #3 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	532	$638,096
2	NVS	Novartis AG	3,514	$550,714
3	NVO	Novo Nordisk A S This page	11,461	$549,440
4	JNJ	Johnson & Johnson	1,733	$440,130
5	GSK	GSK plc	8,312	$435,715
6	AZN	Astrazeneca PLC	2,120	$401,994
7	AMGN	Amgen Inc	797	$288,609
8	SNY	Sanofi	6,375	$271,957

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$549,440	11,461	+25.9%	Shares	Sole	2026-07-17
2026-03-31	$334,425	9,100	+1.4%	Shares	Sole	2026-05-06
2025-12-31	$456,393	8,970	-30.0%	Shares	Sole	2026-02-03
2025-09-30	$711,492	12,822	+95.7%	Shares	Sole	2025-11-05
2025-06-30	$452,219	6,552	+2.2%	Shares	Sole	2025-07-08
2025-03-31	$444,971	6,408	+12.2%	Shares	Sole	2025-05-05
2024-12-31	$491,088	5,709	+1.0%	Shares	Sole	2025-02-10
2024-09-30	$672,983	5,652	+3.3%	Shares	Sole	2024-11-12
2024-06-30	$780,787	5,470	-7.0%	Shares	Sole	2024-08-06
2024-03-31	$755,377	5,883	-3.1%	Shares	Sole	2024-05-06
2023-12-31	$628,355	6,074	-3.8%	Shares	Sole	2024-02-06
2023-09-30	$574,377	6,316	+100.8%	Shares	Sole	2023-11-13
2023-06-30	$509,117	3,146	+4.3%	Shares	Sole	2023-08-11
2023-03-31	$480,125	3,017	-8.6%	Shares	Sole	2023-05-12
2022-12-31	$446,892	3,302	—	Shares	Sole	2023-01-17
No filing history on record for this holder in this stock.